Inicio/Acciones/CRON

CRON

USD

Cronos Group Inc. Common Share

$2.480+0.030 (1.224%)

Precio en Tiempo Real

Healthcare

Drug Manufacturers - Specialty & Generic

Canadá

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.450

Máximo

$2.500

Mínimo

$2.425

Volumen

1.24M

Fundamentos de la Empresa

Capitalización de Mercado

949.6M

Industria

Drug Manufacturers - Specialty & Generic

País

Canada

Estadísticas de Negociación

Volumen Promedio

2.79M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.6Actual $2.480Máximo $3.16

Noticias Relacionadas

1 nov 2025 · 12:00

CNBC

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

28 oct 2025 · 11:30

GlobeNewswire

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabinoid company, announced today that it is welcoming back its limited-edition Caramel Green

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

23 oct 2025 · 11:30

GlobeNewswire

Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET.